CYTOKINETICS INC — Director's Dealing 2022

Mar 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2022-03-02

Reporting Person: Callos Andrew (EVP, Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-02	Common Stock	A	20000	$0.0	Acquired	26196	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-02	Incentive Stock Option (right to buy)	$37.63	A	13285	Acquired	2032-03-01	Common Stock (13285)	Direct
2022-03-02	Non-Qualified Stock Option (right to buy)	$37.63	A	31715	Acquired	2032-03-01	Common Stock (31715)	Direct

Footnotes

F1: Comprised of restricted stock units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant.

F2: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant.